EE+ POEM Archive
Sotagliflozin reduces hospitalizations and urgent visits for heart failure, but has no mortality benefit (SCORED)
Sotagliflozin reduces hospitalizations and urgent visits for heart failure, but has no mortality benefit (SCORED) is a topic covered in the EE+ POEM Archive.
To view the entire topic, please log in or purchase a subscription.
Evidence Central is an integrated web and mobile solution that helps clinicians quickly answer etiology, diagnosis, treatment, and prognosis questions using the latest evidence-based research. Explore these free sample topics:
There's more to see -- the rest of this topic is available only to subscribers.
Citation
Barry, Henry, et al., editors. "Sotagliflozin Reduces Hospitalizations and Urgent Visits for Heart Failure, but Has No Mortality Benefit (SCORED)." EE+ POEM Archive, John Wiley & Sons, 2019. Evidence Central, evidence.unboundmedicine.com/evidence/view/infoPOEMs/1315294/all/Sotagliflozin_reduces_hospitalizations_and_urgent_visits_for_heart_failure__but_has_no_mortality_benefit__SCORED_.
Sotagliflozin reduces hospitalizations and urgent visits for heart failure, but has no mortality benefit (SCORED). In: Barry HH, Ebell MHM, Shaughnessy AFA, et al, eds. EE+ POEM Archive. John Wiley & Sons; 2019. https://evidence.unboundmedicine.com/evidence/view/infoPOEMs/1315294/all/Sotagliflozin_reduces_hospitalizations_and_urgent_visits_for_heart_failure__but_has_no_mortality_benefit__SCORED_. Accessed March 26, 2023.
Sotagliflozin reduces hospitalizations and urgent visits for heart failure, but has no mortality benefit (SCORED). (2019). In Barry, H., Ebell, M. H., Shaughnessy, A. F., & Slawson, D. C. (Eds.), EE+ POEM Archive. John Wiley & Sons. https://evidence.unboundmedicine.com/evidence/view/infoPOEMs/1315294/all/Sotagliflozin_reduces_hospitalizations_and_urgent_visits_for_heart_failure__but_has_no_mortality_benefit__SCORED_
Sotagliflozin Reduces Hospitalizations and Urgent Visits for Heart Failure, but Has No Mortality Benefit (SCORED) [Internet]. In: Barry HH, Ebell MHM, Shaughnessy AFA, Slawson DCD, editors. EE+ POEM Archive. John Wiley & Sons; 2019. [cited 2023 March 26]. Available from: https://evidence.unboundmedicine.com/evidence/view/infoPOEMs/1315294/all/Sotagliflozin_reduces_hospitalizations_and_urgent_visits_for_heart_failure__but_has_no_mortality_benefit__SCORED_.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Sotagliflozin reduces hospitalizations and urgent visits for heart failure, but has no mortality benefit (SCORED)
ID - 1315294
ED - Barry,Henry,
ED - Ebell,Mark H,
ED - Shaughnessy,Allen F,
ED - Slawson,David C,
BT - EE+ POEM Archive
UR - https://evidence.unboundmedicine.com/evidence/view/infoPOEMs/1315294/all/Sotagliflozin_reduces_hospitalizations_and_urgent_visits_for_heart_failure__but_has_no_mortality_benefit__SCORED_
PB - John Wiley & Sons
DB - Evidence Central
DP - Unbound Medicine
ER -
